
What smart money is saying about RadNet
1 fund in our archive has pitched RadNet — most recently Clearbridge SMid Cap Growth Strategy in December 2024.
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
Get an email when a fund writes about it
Position history
Between Q4 2024 and Q2 2026, 1 fund letter reported a position in RadNet, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 0 | 0 |
| Q4 2024 | 0 | 0 | 0 | 1 |
Fund activity · 1 position
- HoldsBaron Health Care FundJune 2026
Listed in Baron Health Care Fund’s reported holdings.
Read the letterRadNet
Fund coverage · 1 thesis
- Clearbridge SMid Cap Growth StrategyDecember 2024
RadNet is a growing player in the health care sector, benefiting from a shift to freestanding diagnostic imaging centers, with growth potential through geographic expansion and AI applications.
Read the full thesis
Read every full thesis on RadNet
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→